BK virus encephalitis with thrombotic microangiopathy in an allogeneic hematopoietic stem cell transplant recipient

Transplant Infectious Disease

Volumn 13, Issue 2, 2011, Pages 161-167

  Lopes da Silva, R ^a,b   Ferreira, I ^a   Teixeira, G ^a   Cordeiro, D ^c   Mafra, M ^d   Costa, I ^d   Bravo Marques, J M ^d   Abecasis, M ^a  

^a Instituto Portugues de Oncologia de Lisboa   (Portugal)

^b HOSPITAL DE SANTO ANTÓNIO DOS CAPUCHOS   (Portugal)

^c NATIONAL INSTITUTE OF HEALTH DR RICARDO JORGE   (Portugal)

^d INSTITUTO PORTUGUÊS DE ONCOLOGIA DE LISBOA FRANCISCO GENTIL   (Portugal)

Author keywords

Allogeneic hematopoietic stem cell transplant; BK virus encephalitis; Immunosuppression; Thrombotic microangiopathy

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; BILIRUBIN; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DEXAMETHASONE; FOSCARNET; FRESH FROZEN PLASMA; HAPTOGLOBIN; LACTATE DEHYDROGENASE; MEROPENEM; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BK VIRUS; BRAIN BIOPSY; CASE REPORT; CHRONIC GRAFT VERSUS HOST DISEASE; CONFUSION; DEMYELINATION; DISEASE ASSOCIATION; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FEVER; GLIOSIS; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HEMOLYTIC ANEMIA; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTIC INFILTRATION; MENINGOENCEPHALITIS; MESENCHYMAL STEM CELL TRANSPLANTATION; MYELODYSPLASTIC SYNDROME; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PSYCHOMOTOR RETARDATION; SLURRED SPEECH; THROMBOTIC THROMBOCYTOPENIC PURPURA; VIRUS DETECTION; VIRUS ENCEPHALITIS;

BK VIRUS; ENCEPHALITIS, VIRAL; FATAL OUTCOME; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MIDDLE AGED; POLYOMAVIRUS INFECTIONS; TUMOR VIRUS INFECTIONS;

EID: 79953313595     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2010.00581.x     Document Type: Article

References (48)

1. Gardner SD, Fieldman AM, Coleman DV, Hulme B. New human papovavirus (B.K.) isolated from urine after renal transplantation. Lancet 1971; 1 (7712): 1253-1257.
2. Reploeg MD, Storch GA, Clifford DB. BK virus: a clinical review. Clin Infect Dis 2001; 33 (2): 191-202.
3. Shah KV, Daniel RW, Warszawski RM. High prevalence of antibodies to BK virus, an SV40-related papopavirus, in residents in Maryland. J Infect Dis 1973; 128 (6): 784-787.
4. Hirsch HH, Steiger J. Polyomavirus BK. Lancet Infect Dis 2003; 3 (10): 611-623.
5. Hirsch HH. BK virus: opportunity makes a pathogen. Clin Infect Dis 2005; 41 (3): 354-360.
6. Nickeleit V, Hirsch HH, Binet IF, et al. Polyomavirus infection of renal allograft recipients: from latent infection to manifest disease. J Am Soc Nephrol 1999; 10 (5): 1080-1089.
7. Egli A, Infanti L, Dumoulin A, et al. Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors. J Infect Dis 2009; 199 (6): 837-846.
8. Behzad-Behbahani A, Klapper PE, Vallely PJ, Cleator GM. BK virus DNA in CSF of immunocompetent and immunocompromised patients. Arch Dis Child 2003; 88 (2): 174-175.
9. Voltz R, Jäger G, Seelos K, Fuhry L, Hohlfeld R. BK virus encephalitis in an immunocompetent patient. Arch Neurol 1996; 53 (1): 101-103.
10. Vallbracht A, Löhler J, Gossman J, et al. Disseminated BK type polyomavirus infection in an AIDS patient associated with central nervous system disease. Am J Pathol 1993; 143 (1): 29-39.
11. Friedman DP, Flanders AE. MR imaging of BK virus encephalitis. Am J Neuroradiol 2006; 27 (5): 1016-1018.
12. Bratt G, Hammarin AL, Grandien M, et al. BK virus as the cause of meningoencephalitis, retinitis and nephritis in a patient with AIDS. AIDS 1999; 13 (9): 1071-1075.
13. Behre G, Becker M, Christopeit M. BK virus encephalitis in an allogeneic hematopoietic stem cell recipient. Bone Marrow Transplant 2008; 42 (7): 499.
14. Choi CM, Schmaier AH, Snell MR, Lazarus HM. Thrombotic microangiopathy in haematopoietic stem cell transplantation: diagnosis and treatment. Drugs 2009; 69 (2): 183-198.
15. Petrogiannis-Haliotis T, Sakoulas G, Kirby J, et al. BK-related polyomavirus vasculopathy in a renal-transplant recipient. N Engl J Med 2001; 345 (17): 1250-1255.
16. Ho VT, Cutler C, Carter S, et al. Blood and marrow transplant clinical trials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2005; 11 (8): 571-575.
17. Elsner C, Dörries K. Evidence of human polyomavirus BK and JC infection in normal brain tissue. Virology 1992; 191 (1): 72-80.
18. Dropulic LK, Jones RJ. Polyomavirus BK infection in blood and marrow transplant recipients. Bone Marrow Transplant 2008; 41 (1): 11-18.
19. Moake J. Thrombotic microangiopathies: multimers, metalloprotease, and beyond. Clin Transpl Sci 2009; 2 (5): 366-373.
20. Tsai HM. Pathophysiology of thrombotic thrombocytopenic purpura. Int J Hematol 2010; 91 (1): 1-19.
21. Kiss JE. Thrombotic thrombocytopenic purpura: recognition and management. Int J Hematol 2010; 91 (1): 36-45.
22. Richards A, Kavanagh D. Pathogenesis of thrombotic microangiopathy: insights from animal models. Nephron Exp Nephrol 2009; 113 (4): e97-e103.
23. van der Plas RM, Schiphorst ME, Huizinga EG, et al. von Willebrand factor proteolysis is deficient in classic, but not in bone marrow transplantation-associated, thrombotic thrombocytopenic purpura. Blood 1999; 93 (11): 3798-3802.
24. George JN, Li X, McMinn JR, Terrell DR, Vesely SK, Selby GB. Thrombotic thrombocytopenia purpura-hemolytic uremic syndrome following allogeneic HPC transplantation: a diagnostic dilemma. Transfusion 2004; 44 (2): 294-304.
25. Pettitt AR, Clark RE. Thrombotic microangiopathy following bone marrow transplantation. Bone Marrow Transplant 1994; 14 (4): 495-504.
26. Allford SL, Machin SJ. Current understanding of the pathophysiology of thrombotic thrombocytopenic purpura. J Clin Pathol 2000; 53 (7): 497-501.
27. Qu L, Kiss JE. Thrombotic microangiopathy in transplantation and malignancy. Semin Thromb Hemost 2005; 31 (6): 691-699.
28. Uderzo C, Bonanomi S, Busca A, et al. Risk factors and severe outcome in thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation. Transplantation 2006; 82 (5): 638-644.
29. Hachem RR. Thrombotic microangiopathy after lung transplantation: a difficult diagnosis. South Med J 2008; 101 (7): 683-684.
30. Changsirikulchai S, Myerson D, Guthrie KA, McDonald GB, Alpers CE, Hingorani CR. Renal thrombotic microangiopathy after hematopoietic cell transplant: role of GVHD in pathogenesis. Clin J Am Soc Nephrol 2009; 4 (2): 345-353.
31. Baid S, Pascual M, Cosimi AB, Chung RT, Colvin RB, Tolkoff-Rubin N. Viruses and thrombotic microangiopathy. Transplantation 1999; 68 (5): 710-711.
32. Afzal F, Budisavljevic MN, Rajagopalan PR, Baliga PK. Viruses in posttransplant thrombotic microangiopathy. Transplantation 2001; 72 (4): 750.
33. Becker S, Fusco G, Fusco J, et al. Collaborations in HIV Outcomes Research/US Cohort. HIV-associated thrombotic microangiopathy in the era of highly active antiretroviral therapy: an observational study. Clin Infect Dis 2004; 39 (Suppl 5): S267-S275.
34. del Arco A, Martinez MA, Peña JM, et al. Thrombotic thrombocytopenic purpura associated with human immunodeficiency virus infection: demonstration of p24 antigen in endothelial cells. Clin Infect Dis 1993; 17 (3): 360-363.
35. Benjamin M, Terrell DR, Vesely SK, et al. Frequency and significance of HIV infection among patients diagnosed with thrombotic thrombocytopenic purpura. Clin Infect Dis 2009; 48 (8): 1129-1137.
36. Jochimsen F, Gruening W, Arnould T, et al. Thrombotic microangiopathy associated with unusual viral sequences in HIV-1-positive patients. Nephrol Dial Transplant 2004; 19 (5): 1129-1135.
37. Ahmed S, Siddiqui RK, Siddiqui AK, Zaidi SA, Cervia J. HIV associated thrombotic microangiopathy. Postgrad Med J 2002; 78 (923): 520-525.
38. Takatsuka H, Wakae T, Mori A, et al. Endothelial damage caused by cytomegalovirus and human herpesvirus-6. Bone Marrow Transplant 2003; 31 (6): 475-479.
39. Maslo C, Peraldi MN, Desenclos JC, et al. Thrombotic microangiopathy and cytomegalovirus disease in patients infected with human immunodeficiency virus. Clin Infect Dis 1997; 24 (3): 350-355.
40. Jeejeebhoy FM, Zaltzman JS. Thrombotic microangiopathy in association with cytomegalovirus infection in a renal transplant patient: a new treatment strategy. Transplantation 1998; 65 (12): 1645-1648.
41. Herrera GA, Alexander RW, Cooley CF, et al. Cytomegalovirus glomerulopathy: a controversial lesion. Kidney Int 1986; 29 (3): 725-733.
42. Humblot S, Martin T, Pasquali JL, Korganow AS. Blood coagulation disorders during primary cytomegalovirus infection. Arch Intern Med 2001; 161 (17): 2149-2150.
43. Ramasubbu K, Mullick T, Koo A, et al. Thrombotic microangiopathy and cytomegalovirus in liver transplant recipients: a case-based review. Transpl Infect Dis 2003; 5 (2): 98-103.
44. Matsuda Y, Hara J, Miyoshi H, et al. Thrombotic microangiopathy associated with reactivation of human herpesvirus-6 following high-dose chemotherapy with autologous bone marrow transplantation in young children. Bone Marrow Transplant 1999; 24 (8): 919-923.
45. Belford A, Myles O, Magill A, Wang J, Myhand RC, Waselenko JK. Thrombotic microangiopathy (TMA) and stroke due to human herpesvirus-6 (HHV-6) reactivation in an adult receiving high-dose melphalan with autologous peripheral stem cell transplantation. Am J Hematol 2004; 76 (2): 156-162.
46. Murer L, Zacchello G, Bianchi D, et al. Thrombotic microangiopathy associated with parvovirus B 19 infection after renal transplantation. J Am Soc Nephrol 2000; 11 (16): 1132-1137.
47. Baid S, Pascual M, Williams WW Jr, et al. Renal thrombotic microangiopathy associated with anticardiolipin antibodies in hepatitis C-positive renal allograft recipients. J Am Soc Nephrol 1999; 10 (1): 146-153.
48. Wiersinga WJ, Scheepstra CG, Kasanardjo JS, de Vries PJ, Zaaijer H, Geerlings SE. Dengue fever-induced hemolytic uremic syndrome. Clin Infect Dis 2006; 43 (6): 800-801.